Results 1 to 10 of about 16,490 (139)
Objective To explore the DPP4 expression changes and functions in ovarian cancer (OV), as well as the regulation mechanism for DDP4. Methods GEPIA2, GSE18520, GSE26712 and UALCAN were used to analyze differences in DPP4 expression between OV tumors and ...
Zhao-Wei Gao, Xia-Nan Wu, Ke Dong
exaly +2 more sources
DPP4 as a Potential Candidate in Cardiovascular Disease
Si-Yu Chen,1,* Xiang-Quan Kong,1,2,* Ke-Fan Zhang,3,* Shuai Luo,1 Feng Wang,1 Jun-Jie Zhang1,2 1Department of Cardiology, Nanjing First Hospital, Nanjing Medical University, Nanjing, People’s Republic of China; 2Department of Cardiology ...
Jun-Jie Zhang
exaly +2 more sources
Background: Increase in circulating dipeptidyl peptidase-4 (DPP4) activity and levels has been reported to associate both with hyperglycemia and obesity.
Jit Sarkar, Titli Nargis, Sujoy Ghosh
exaly +3 more sources
Dipeptidyl peptidase 4 (DPP4) is a glycoprotein of 110 kDa, which is ubiquitously expressed on the surface of a variety of cells. This exopeptidase selectively cleaves N-terminal dipeptides from a variety of substrates, including cytokines, growth ...
Jürgen Eckel
exaly +3 more sources
Proteases catalyse irreversible posttranslational modifications that often alter a biological function of the substrate. The protease dipeptidyl peptidase 4 (DPP4) is a pharmacological target in type 2 diabetes therapy primarily because it inactivates ...
Cecy R Xi +2 more
exaly +3 more sources
Identification and validation of DPP4 in predicting the prognosis of clear cell RCC [PDF]
Dipeptidyl peptidase-4 (DPP4) has been implicated in tumor progression, yet its role in clear cell renal cell carcinoma (KIRC) remains poorly understood. This study aimed to comprehensively investigate the expression profile, prognostic significance, and
Min Luo, Peifeng Li
doaj +2 more sources
Prognostic and Therapeutic Significance of DPP4 in SMARCA4-Deficient Non–Small Cell Lung Cancer [PDF]
Introduction SMARCA4-deficient NSCLC is an aggressive subtype lacking robust biomarkers and therapeutic targets. To define the expression pattern and clinical significance of DPP4 in SMARCA4-dNSCLC and explore whether DPP4 may represent a therapeutic ...
Chaopeng Chen +8 more
doaj +2 more sources
Elevated hepatic DPP4 activity promotes insulin resistance and non-alcoholic fatty liver disease
Objective: Increased hepatic expression of dipeptidyl peptidase 4 (DPP4) is associated with non-alcoholic fatty liver disease (NAFLD). Whether this is causative for the development of NAFLD is not yet clarified.
Christian Baumeier +2 more
exaly +3 more sources
KLK5 induces shedding of DPP4 from circulatory Th17 cells in type 2 diabetes
Objective: Increasing plasma levels and activity of dipeptidyl peptidase-4 (DPP4 or CD26) are associated with rapid progression of metabolic syndrome to overt type 2 diabetes mellitus (T2DM).
Titli Nargis +2 more
exaly +3 more sources
Dual-source DPP4 drives intestinal fibrosis in Crohn’s disease: synergistic therapeutic targeting of host and microbiota pathways [PDF]
Crohn’s disease (CD), a chronic inflammatory bowel disorder, often progresses to intestinal fibrosis and stricture, yet no effective anti-fibrotic treatments exist.
Jiajia Li +6 more
doaj +2 more sources

